1, D Ravine, Gibson RN, Walker GR, et al Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1 Lancet;343:824-27, 1994. Î 2. Gabow PA, Johnson AM, Kaehny WD, et al. Factors affecting the progression of renal disease in autosomal dominant polycystic kidney disease. Kidney Ini 41:1311-1319,1992.
3- Sise C, Kusaka M. Wetzel LH, et al. Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography Kidney Int 5H: 2492-2501. 2000.
4. King FB. Reed JE, Bergstralh EJ, et al. Quantification and longitudinal trends of kidney, renal cyst and renal parenchyma volumes in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 11: 1505-1511, 2000.
5. Frick-Brosnahan GM, Belz MM, Mc Falın KK, et al. Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: A Longitudinal Study. Am J Kid Dis. 39: 1127-1134, 2002.
! 6. King FB, Torres VE, Brummer ME, et al. Magnetic resonance measurements of renal bkx)d flow as a marker of disease severity in autosomal-dom i nan l polycystic kidney disease. Kid-nei Int. 64:2214-2221, 2003¬7. O'Neill WC. Robbin ML. Bae KT, et al. Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: The consortium of renal imaging studies in polycystic kidney disease!CRISP). Am J Kid Dis.46: 1058-1064, 2005. H. Ubara Y, Kalori H, Tagami T, el al. Transcatheter Renal arterial embolization therapy on a paiieni with polycystic kidney disease on hemodialysis. Am J Kid Dis. 34:926-931,1999. 9. Ubara Y, Tagami T, Sawa N, et al. Renal contraction therapy for enlarged polysytic kidneys by transcatheter arterial embolization in hemodialysis patients. Am J Kid Dis. 39: 571¬579,2002.
34
Thank you for copying data from http://www.arastirmax.com
